Dr. Girish B. Mahajan is Executive Vice President–Microbiology at HiMedia Laboratories, India. A Ph.D. He holds a Ph.D. in Microbiology and is an alumnus of the Institute of Chemical Technology, Mumbai. He brings over 28 years of experience in pharmaceutical and biotechnology research, including leadership roles at Piramal Enterprises and OmniActive Health Technologies. His expertise spans antimicrobial drug discovery, microbial identification, fermentation, bioprocess development, and translational biotechnology. He has contributed to over 150 publications and 20 patents. As an active member of ASM and AMI, he serves as a scientific mentor, journal reviewer, and academic advisor, fostering meaningful industry–academia partnerships and the responsible commercialization of microbiological innovations.

Antimicrobial drug discovery and development; antibiotic resistance and novel antimicrobial agents; pharmaceutical and industrial microbiology; microbial identification and characterization using MALDI-TOF mass spectrometry; microbial fermentation and bioprocess technology; marine microbial biotechnology and bioactive natural products; probiotics, prebiotics and microbiome research; microbial biotechnology and sustainable biomanufacturing; analytical method development and validation; translational biotechnology, research commercialization and industry–academia collaborations.